{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:10:37Z","timestamp":1791400237822,"version":"4.3.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ejphar.2008.01.045","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T09:43:17Z","timestamp":1202895797000},"page":"118-124","source":"Crossref","is-referenced-by-count":144,"title":["Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice"],"prefix":"10.1016","volume":"584","author":[{"given":"Shuqin","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizbeth","family":"Hoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen","family":"Tetzloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"van Heek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce J.","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2008.01.045_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","article-title":"The natural history of nonalcoholic fatty liver disease: a population-based cohort study","volume":"129","author":"Adams","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.01.045_bib2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2008.01.045_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2008.01.045_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.ejphar.2008.01.045_bib5","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.3748\/wjg.v12.i27.4369","article-title":"Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease","volume":"12","author":"Assy","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2008.01.045_bib6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1194\/jlr.M600488-JLR200","article-title":"Lysosomal unesterified cholesterol content correlates with liver cell death in murine Niemann-Pick type C disease","volume":"48","author":"Beltroy","year":"2007","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ejphar.2008.01.045_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-9120(93)90015-X","article-title":"Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts","volume":"26","author":"Carr","year":"1993","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejphar.2008.01.045_bib8","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1073\/pnas.0508483103","article-title":"Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels","volume":"103","author":"Cohen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2008.01.045_bib9","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1074\/jbc.M409110200","article-title":"Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia","volume":"280","author":"Davies","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.01.045_bib10","doi-asserted-by":"crossref","first-page":"33586","DOI":"10.1074\/jbc.M405817200","article-title":"Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis","volume":"279","author":"Davis","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2008.01.045_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200502078","article-title":"Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor","volume":"171","author":"Devries-Seimon","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2008.01.045_bib12","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2008.01.045_bib13","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2008.01.045_bib14","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.mehy.2006.05.041","article-title":"Unexpected beneficial effect in the use of ezetimibe in non-alcoholic fatty liver disease","volume":"67","author":"Hughes","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ejphar.2008.01.045_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.hepres.2005.09.024","article-title":"The role of leptin in progression of non-alcoholic fatty liver disease","volume":"33","author":"Ikejima","year":"2005","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejphar.2008.01.045_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1292\/jvms.67.235","article-title":"Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats","volume":"67","author":"Jeong","year":"2005","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejphar.2008.01.045_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","article-title":"Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies","volume":"18","author":"Kirsch","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2008.01.045_bib18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1527-3466.2003.tb00123.x","article-title":"Ezetimibe: a first-in-class, novel cholesterol absorption inhibitor","volume":"21","author":"Lipka","year":"2003","journal-title":"Cardiovasc. Drug. Rev."},{"key":"10.1016\/j.ejphar.2008.01.045_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cmet.2006.07.006","article-title":"Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis","volume":"4","author":"Mari","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2008.01.045_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1301\/002966402320387224","article-title":"Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants","volume":"60","author":"Mehta","year":"2002","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2008.01.045_bib21","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.2337\/diabetes.54.12.3530","article-title":"Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL\/6 mice","volume":"54","author":"Park","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2008.01.045_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1053\/gast.2003.50004","article-title":"Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States","volume":"124","author":"Ruhl","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2008.01.045_bib23","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000116766.31036.03","article-title":"Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia","volume":"109","author":"Salen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2008.01.045_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1194\/jlr.M600439-JLR200","article-title":"The molecular mechanisms underlying the reduction of low density lipoprotein apoB-100 by ezetimibe plus simvastatin","volume":"48","author":"Telford","year":"2007","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ejphar.2008.01.045_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI119171","article-title":"Diet-induced obese mice develop peripheral, but not central, resistance to leptin","volume":"99","author":"Van Heek","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2008.01.045_bib26","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2337\/diabetes.50.6.1330","article-title":"Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters","volume":"50","author":"van Heek","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2008.01.045_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)00825-1","article-title":"The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys","volume":"415","author":"van Heek","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2008.01.045_bib28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1210\/en.2005-0570","article-title":"Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990800112X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429990800112X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T14:59:21Z","timestamp":1546268361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429990800112X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S001429990800112X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2008.01.045","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}